Lymphoplasmacytic lymphoma screening: Difference between revisions
Created page with "__NOTOC__ {{Lymphoplasmacytic lymphoma}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Accordin..." |
Sara Mohsin (talk | contribs) |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Lymphoplasmacytic lymphoma}} | {{Lymphoplasmacytic lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{S.M.}} | ||
==Overview== | ==Overview== | ||
According to the the [[United States Preventive Services Task Force]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient [[evidence]] to recommend routine [[screening]] for [[lymphoplasmacytic lymphoma]]. | |||
==Screening== | ==Screening== | ||
According to the the [[United States Preventive Services Task Force]] ([[USPSTF]]), there is insufficient [[evidence]] to recommend routine [[screening]] for [[lymphoplasmacytic lymphoma]].<ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=waldenstrom+macroglobulinemia Accessed on November 10, 2015</ref> | |||
According to the [ | |||
==References== | ==References== | ||
| Line 33: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Blood]] | |||
[[Category:Hematology]] | |||
Latest revision as of 13:53, 15 August 2019
|
Lymphoplasmacytic lymphoma Microchapters |
|
Differentiating Lymphoplasmacytic Lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphoplasmacytic lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Lymphoplasmacytic lymphoma screening |
|
Risk calculators and risk factors for Lymphoplasmacytic lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
According to the the United States Preventive Services Task Force (USPSTF), there is insufficient evidence to recommend routine screening for lymphoplasmacytic lymphoma.
Screening
According to the the United States Preventive Services Task Force (USPSTF), there is insufficient evidence to recommend routine screening for lymphoplasmacytic lymphoma.[1]
References
- ↑ Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=waldenstrom+macroglobulinemia Accessed on November 10, 2015